Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptides vs Traditional Hip Pain Treatments

NSAIDs (Ibuprofen, Naproxen) COX enzyme inhibition. Blocks prostaglandin synthesis to reduce inflammation Pain relief within 30–60 minutes None. Symptomatic only Does not address cartilage degradation; chronic use linked to GI bleeding and cardiovascular risk

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • NSAIDs (Ibuprofen, Naproxen)
  • COX enzyme inhibition. Blocks prostaglandin synthesis to reduce inflammation
  • Pain relief within 30–60 minutes
  • None. Symptomatic only
  • Does not address cartilage degradation; chronic use linked to GI bleeding and cardiovascular risk
  • Physical Therapy
  • Strengthens supporting musculature to offload damaged structures
  • 6–12 weeks for functional improvement
  • Indirect. Strengthens surrounding tissue but does not regenerate cartilage or repair labrum
  • Limited efficacy for structural damage; requires compliance
  • Corticosteroid Injections
  • Suppresses local immune response and cytokine production
  • 24–72 hours for inflammation reduction
  • None. May accelerate cartilage breakdown with repeated use
  • Temporary relief; studies show cartilage thinning with >3 injections annually
  • PRP (Platelet-Rich Plasma)
  • Delivers autologous growth factors (PDGF, TGF-β, VEGF) to injury site
  • 4–12 weeks for tissue remodeling
  • Moderate. Growth factor concentration varies widely by preparation method
  • Inconsistent outcomes; lacks standardized protocols
  • BPC-157 + TB-500 Peptides
  • Activates FAK-paxillin pathway (BPC-157) and VEGF-driven angiogenesis (TB-500) for collagen synthesis
  • 2–6 weeks for pain reduction; 8–12 weeks for structural repair
  • High. Promotes fibroblast migration, collagen deposition, and capillary formation
  • Requires precise dosing and sourcing; human trials limited to case reports